Fluoride And Thimerosol Information
12.01.1999
FLUORIDE AND THIMEROSOL INFORMATION
News
FDA Bans Mercury Compound Thimerosal in any over-the-counter
drug preparation Says Safety and Effectiveness Not Established Neglects Fact
That Thimerosal is Ingredient of Many Vaccines
In a rule effective 22 October 1998, published in the Federal Register 63(77):
19799-19802, 22 April 1998, the FDA has banned the use of mercury and 15 of
its compounds, which include Thimerosal and Mercurochrome, saying that
"safety and effectiveness have not been established for the ingrediants...
manufacturers have not submitted the necessary data". Thimerosal is used
widely as an adjuvant (additive) in the vaccine industry. On top of that, it
has been widely known for some time that Thimerosal ( used by the vaccine
industry as a mercury "disinfectant/perservative") can result in
brain injury and autoimmune disease. Other vaccine adjuvants routinely
injected into babies, children and adults include phenol (a carcinogen),
formaldehyde (used to embalm bodies), aluminum (contributes to brain disease),
ethylene glycol (anti-freeze), and antibiotics (oblivious to allergic
reactions).
Also in the vaccines are animal viruses too expensive to screen out. The
vaccine industry, knowing this for the last 40 years, amounts to a criminal
enterprise, worthy of corporate charter withdrawal for all the companies
involved. Curiously, and understandably from their perspective, the FDA does
not halt Thimerosal use in vaccines. What is also curious is that the FDA also
continues to allow mercury amalgam fillings, each of which contributes a
body-load of 650 mg of elemental toxic mercury. The FDA has categorized
mercury and its compounds as "drugs", but its Dental Division
classifies mercury amalgam as a "dental device", presumably to aid
and abet the USPHS and the ADA, who face massive numbers of lawsuits as it is.
Lawsuits involving amalgam have sprouted up in Canada in 1998, promising a
litigation load which could cost billions.
American Dental Association Has Financial Interest In Enamelon Fluoride
Toothpaste with "highest fluoride uptake level yet"
Rockefeller Agencies and Military Connections in Enamelon
The company Enamelon, Incorporated is a corporation chartered in the state of
Delaware that maintains a main office at 15 Kimball Avenue, Yonkers, New York
10704, with a phone number of (914) 237-1308. The chairman of the board is Dr.
Steven R. Fox. According to documents filed with the Security and Exchange
Commission on September 8, 1997, Dr. Steven Fox, chairman of the board, is an
active member of the American Dental Association. The ADA's Executive
Director, Dr. John Zapp, has heavily vested financial interests in the
company. President and CEO is D. Brooks Cole, formerly of Vick Chemical
Company. Vice president Norman Usen was also president of Nu-Products. Vice
president of technical research Anthony E. Winston was the ADA/FDA interface
for the company. Winston is the holder or co-holder of more than 60 United
States patents, of which 14 are for toothpaste products. Since August 1994, an
ex-Army General has functioned as Enamelon's director. General (Ret) S.N.
Bhaskar, D.D.S., M.S., Ph.D., was a member of the Dental Research Advisory
Committee to the US Army, and is head of Enamelon's "scientific advisory
board" (SAB) . Also on the SAB is Robert Bruce Merrifield, Ph.D., the
recipient of the 1984 Nobel Prize in Chemistry as well as numerous other
scientific honors, and has been the John D. Rockefeller, Jr. Professor at The
Rockefeller University since 1966. He has been a member of the faculty at The
Rockefeller Institute for Medical Research since 1963. The SAB also works in
cooperation with the Company and the scientists at the American Dental
Association's Paffenbarger Research Center at the United States Government's
National Institute of Standards and Technology.
The company has been granted five US patents for methods and materials that
supply soluble calcium and phosphate salts to teeth to enhance
remineralization together with sodium fluoride. The Company is planning to
follow-up the introduction of its all-family toothpaste with a toothpaste for
sensitive teeth with the active ingredients sodium fluoride and the
desensitizing agent potassium nitrate.
According to the S-1 form filed with the SEC, "the Company intends to
continue to conduct human clinical studies of Enamelon(TM) toothpaste in order
to begin to establish additional advertising claims concerning efficacy in
humans. The Company believes that these advertising claims will distinguish
Enamelon(TM) toothpaste from competitors' products and give the Company a
competitive advantage. However, there can be no assurance that the results of
the human clinical studies will substantiate the anticipated advertising
claims."
Toothpaste products are subject to regulation by the FDA. The FDA has
published a final monograph, Anticaries Drug Products for Over-the-Counter
Human Use (the "Monograph"), for over-the-counter anticaries drug
products. The Monograph establishes conditions under which OTC drug products
that aid in the prevention of tooth decay generally are recognized as being
safe and effective and not misbranded. The Company's products may be lawfully
marketed without being required to file a New Drug Application (an "NDA")
with the FDA, if they use as their sole active ingredient one of the active
ingredients permitted in the Monograph and only make labeling claims permitted
by the Monograph. The Company's toothpaste and other proposed OTC drug
products have been and are being developed with the sole active ingredient
being sodium fluoride, an active ingredient permitted under the Monograph.
As far as liability is concerned, according to the SEC document "Although
the Company has no intention of marketing any product without reasonable
belief in its safety and efficacy when used in accordance with its
instructions, misuse of the Company's products may result in consumer injury.
In addition, future developments, including possible adverse medical studies
and associated negative publicity, could have a material adverse impact on the
market for the Company's products and on its results of operations."
Also, "The human studies are being conducted under substantially
different conditions from those of the laboratory tests, and there can be no
assurance that the human studies will support additional advertising claims,
including comparative claims."
How powerful is the fluoride preparation?
According to the SEC document, "The results of the in vitro studies
generally demonstrated that the prototype toothpaste formulations using the
Enamelon Technologies resulted in increased fluoride uptake over that obtained
by the prevailing industry
Toothpaste Maker Admits "Fluorides are drugs"
According to a recent news story in the Wall Street Journal "Some Young
Children Get Too Much Fluoride" Monday, December 21, 1998, Terry Loftus,
a spokesman for Procter and Gamble, which makes Crest fluoridated toothpaste,
"toothpaste with fluoride is considered an over-the-counter drug. and
parents should supervise their children under six when using it".
CDC Ignores Medical Complications from Fluorosis USPHS/ADA Policy of
Misinformation to Public Although the CDC just completed a study on fluorides
and diet, to be published early in 1999, which indicated that children are
exposed to fluorides from a variety of sources, the CDC inaccurately maintains
that "excess fluoride causes problems that are cosmetic, with no other
adverse health consequences". The CDC here is guilty of a bold-faced lie,
since a great body of international scientific literature indicates that
neurophysiological damage has long since existed by the time fluorosis shows
up in the teeth and bones. A recent national study found that almost 25% of
children in the United States have some form of fluorosis, which means that at
least that many children have had their intelligence and behavior altered
prior to the appearance of brown or white spots on the teeth. CDC policy on
the nature of fluorides and their effects closely follows political policy of
the USPHS and the ADA, which has a vested interest in the sales of fluoridated
toothpastes, and in avoiding national litigation and lawsuits because of the
deliberate misinformation they issue on the effect of fluorides on the body
and brain.
If you missed it, you can go to either a SHORT explanation of the whole story, or a detailed explanation on ONE PAGE.
On this page you are getting more detail on one part of the story, but on either of those pages you can get the broad picture.
Don't miss reading one of them.
You can actually spend many hours on this web site, depending on the depth of research and reading you want to do.
There are an amazing 4,000 pages here -- more information on these general subjects than almost all other web sites combined! At some point along the way you will probably say, "Karl's crazy," and leave never to return to this site, or you will say "I want to try some of that oral chelation formula he writes about!"
SUBSCRIBE:
The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.
You can view more than 50 back issues of this publication by clicking here.
The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.
It is automatically published on the Tuesday night just before the first Wednesday of every month.
You can subscribe to this free monthly electronic letter by entering your eMail address and name below.
You will then automatically receive a request for confirmation, sent to whatever address you have entered.
If you do NOT receive this confirmation request, then you will not be subscribed.
There may have been an error with your address and you should resubmit.
The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.
When you receive this confirmation request you must reply to it, or your subscription will not become active.
No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL:
You can remove yourself from the subscription list in several different ways.
Click here to read about this entire newsletter system.
Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.
If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.
Thus, no one else can unsubscribe you, from some other computer, without your knowledge.
But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message:
When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.
Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.
You can select particular information you would like to receive, along with the free cassette tape and catalog.
You can reach Vibrant Life in many ways, including by mail to
Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.
Within the US and Canada, use
the toll free number: (800) 523-4521,
the local number: (818) 558-1799,
the FAX: (818) 558-7299,
eMail to kimberly@oralchelation.com
or any one of the hundreds of message forms throughout the 50 web sites.
Vibrant Life normally ships the same day we get an order.
There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.
Check out our companion site, at: http://www.oralchelation.net
where Karl's 2000 page book is published. Karl Loren is the author and
webmaster for this BOOK, as well as
for another web site about ORAL CHELATION.
His personal philosophical articles are at PHILOSOPHY.
Copyright © May 20, 2008 6:25 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.
Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:
One, that some form of copyright notice is included in every copy distributed or copied,
showing the copyright belonging to Vibrant Life, Burbank, CA, at
www.oralchelation.com .
The second condition is that the material is not to be used for any purpose contrary to
the purposes and objectives of this site.
This permission does not extend to materials on this site which are copyrighted by others.
